A nurse is preparing a client for fluorescein angiography to evaluate diabetic retinopathy. Which assessment finding would be most important for the nurse to report to the healthcare provider before the procedure?

A history of severe allergic reaction to shellfish/iodine is critical to report due to high risk of anaphylaxis from fluorescein dye. Other findings like elevated blood glucose or mild eye discomfort are less urgent.

Understanding the Procedure and the Priority Concern

Fluorescein angiography is a diagnostic procedure used to visualize the retinal and choroidal circulation. A water-soluble dye called fluorescein sodium is injected intravenously, and a specialized camera captures serial photographs as the dye travels through the ocular blood vessels. While generally considered safe, the procedure carries a risk of adverse reactions to the injected dye. The most critical pre-procedure nursing responsibility is identifying clients at risk for a severe hypersensitivity reaction. The guideline on preoperative standards for vitreoretinal surgery highlights the importance of thorough preoperative assessments to determine surgical or procedural indications and evaluate patient conditions, which directly includes identifying allergy risks ^[1].

Analysis of the Correct Answer

The most important finding to report is a history of a severe allergic reaction to shellfish and iodine. This is a classic NCLEX-RN concept that requires a nuanced, evidence-based understanding.

Historically, a link was assumed between allergies to shellfish/iodine and contrast dye reactions. However, current evidence clarifies this misconception. The allergen in shellfish is tropomyosin, a muscle protein, not iodine. Furthermore, an "iodine allergy" is a misnomer; iodine is an essential element for thyroid hormone synthesis and cannot be an allergen itself. Reactions to iodinated contrast media are related to the osmolarity and chemical structure of the contrast molecule, not the iodine content.

Despite this lack of a direct immunological cross-reactivity, a reported severe shellfish allergy or a documented reaction to iodinated contrast serves as a significant clinical red flag. It identifies a client with an atopic predisposition, meaning their immune system is primed to overreact to foreign substances. A systematic review on the safety of indocyanine green (ICG), a dye with a similar clinical profile, reinforces this point. The research specifically investigated whether ICG posed a significant risk for patients with a history of allergies to iodinated contrast, concluding that while the direct risk from cross-reactivity is low, a history of any severe allergy is a crucial part of the pre-procedure safety evaluation ^[2]. Therefore, reporting this history is vital because it alerts the healthcare provider to a higher baseline risk for any hypersensitivity event, prompting potential premedication protocols, having emergency equipment on standby, or choosing an alternative diagnostic method.

Why the Other Options Are Not the Priority

- Blood glucose level of 180 mg/dL (10.0 mmol/L): This value is elevated above normal fasting targets but is not a contraindication to the procedure. Uncontrolled hyperglycemia is the underlying cause of diabetic retinopathy, and the procedure is being performed to evaluate this very condition. While the nurse would document this finding and ensure it is addressed as part of the client's overall diabetes management, it does not pose an immediate procedural risk like anaphylaxis.

- Blood pressure of 150/90 mmHg: This reading indicates Stage 1 hypertension. The nurse should document this and inform the provider, as chronic hypertension can exacerbate diabetic retinopathy. However, in the context of an elective diagnostic procedure, this isolated, mildly elevated reading is not an acute contraindication and is not the most urgent safety concern.

- Complaint of mild eye discomfort: This is an expected finding in a client with retinal vascular pathology and is the reason for the diagnostic test. It does not require immediate reporting to halt or delay the procedure.

Clinical Reasoning and Evidence Synthesis

The nurse's clinical judgment must prioritize the risk of immediate, life-threatening harm. A type I hypersensitivity reaction (anaphylaxis) to the fluorescein dye, though rare, is the most severe potential complication. The foundational nursing concept here is that a client's history of any severe atopic reaction, particularly to injectable substances or shellfish, is a major predictor of a similar response to a new intravenous agent. The research on ICG safety validates this nursing principle by demonstrating that the primary concern is not a theoretical iodine cross-reactivity but the client's intrinsic allergic diathesis ^[2]. This is further supported by the procedural guidelines, which emphasize a comprehensive pre-procedure assessment to mitigate risk ^[1]. The nurse acts as a safety advocate by recognizing this historical finding as the single most critical piece of data requiring immediate communication to the provider to ensure client safety before the dye is injected.